Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 9:00 pm Sale | 2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 15,376,197 5.100% | -6,581,729 (-29.97%) | Filing History |
| 2024-11-14 11:37 am Purchase | 2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 15,582,962 5.300% | 15,582,962 (New Position) | Filing History |
| 2024-11-14 09:31 am Sale | 2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 23,175,000 7.800% | -4,225,000 (-15.42%) | Filing History |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD | WELLINGTON MANAGEMENT GROUP LLP | 23,964,044 8.080% | 8,774,020 (+57.76%) | Filing History |
| 2024-10-07 1:24 pm Sale | 2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD | JPMORGAN CHASE & CO JPM | 12,823,682 4.300% | -4,678,998 (-26.73%) | Filing History |
| 2024-02-14 4:38 pm Purchase | 2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 28,057,456 9.600% | 414,539 (+1.50%) | Filing History |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 21,957,926 7.300% | -6,641,568 (-23.22%) | Filing History |
| 2024-02-14 09:22 am Purchase | 2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 27,400,000 9.300% | 600,000 (+2.24%) | Filing History |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Amicus Therapeutics, Inc. FOLD | VANGUARD GROUP INC | 28,492,486 9.720% | 1,954,115 (+7.36%) | Filing History |
| 2024-02-08 10:05 am Purchase | 2023-12-29 | 13G | Amicus Therapeutics, Inc. FOLD | WELLINGTON MANAGEMENT GROUP LLP | 15,190,024 5.180% | 7,082,677 (+87.36%) | Filing History |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | BlackRock Inc. BLK | 22,985,442 7.800% | 2,851,450 (+14.16%) | Filing History |
| 2024-01-08 09:09 am Purchase | 2023-12-29 | 13G | Amicus Therapeutics, Inc. FOLD | JPMORGAN CHASE & CO JPM | 17,502,680 5.900% | 4,040,756 (+30.02%) | Filing History |
| 2023-12-08 4:31 pm Sale | 2023-11-30 | 13G | Amicus Therapeutics, Inc. FOLD | MORGAN STANLEY MS | 12,303,701 4.200% | -5,281,315 (-30.03%) | Filing History |
| 2023-02-14 4:16 pm Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 28,599,494 9.900% | 194,452 (+0.68%) | Filing History |
| 2023-02-14 2:31 pm Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 27,642,917 9.800% | 286,874 (+1.05%) | Filing History |
| 2023-02-14 09:35 am Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 26,800,000 9.500% | 8,300,000 (+44.86%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD | VANGUARD GROUP INC | 26,538,371 9.450% | 893,187 (+3.48%) | Filing History |
| 2023-02-08 12:42 pm Purchase | 2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD | MORGAN STANLEY MS | 17,585,016 6.300% | 4,847,359 (+38.06%) | Filing History |
| 2023-02-06 2:49 pm Sale | 2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD | WELLINGTON MANAGEMENT GROUP LLP | 8,107,347 2.890% | -18,541,327 (-69.58%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | BlackRock Inc. BLK | 20,133,992 7.200% | 323,644 (+1.63%) | Filing History |